Disorders and Services
Parkinson Disease, Essential Tremor, Tics, Dystonia, Dyskinesias, Myoclonus, Olivopontocerebellar degeneration, PSP; EMG guided neurotoxin injections (“botox”) for Dystonia and Spasticity
Overview and Mission
The Movement Disorders Clinic specializes in disorders that affect movement. These include Parkinson's Disease, Huntington's Chorea, Ataxia, Tremor, Dystonia, Torticollis, and others. While care is provided for all of these disorders, Parkinson's Disease is a special emphasis. Sophisticated techniques have been developed for managing difficult patients. Often experimental medications can be provided in those cases where traditional therapy has not been successful. We also offer Botulinum Toxin (Botox) therapy for those requiring it, and treatment of tremor and Parkinson's Disease with Deep Brain Stimulator therapy.
Scott J. Sherman, MD, PhD is the Director of the Movement Disorders Clinic at The University of Arizona. The Movement Disorders Clinic provides sub-specialized clinical care for patients with Parkinson's disease, tremor, and a variety of other neurological problems which lead to difficulty with movement. The clinic uses a team-oriented approach including input from pharmacists, physical therapists, speech therapists and provides training for medical students, residents, and fellows.
The Movement Disorders Clinic also provides educational updates for the public and advanced training opportunities for community physicians.
Dr. Sherman is involved in both clinical and basic laboratory research. His current clinical interests include testing new drugs for the treatment of Parkinson's disease, the use of physical rehabilitation in Parkinson's disease, and the use of deep brain stimulation for control of tremor and other movement problems. His basic laboratory research program focuses on using gene therapy to control the electrical activity of brain cells. In many movement disorders, the brain cells in specific locations of the brain become overactive. The use of engineered, specialized viruses to introduce new genes into these cells may one day allow correction of this overactivity.
Scott Sherman, MD, PhD
Sue Bose, MD
Hong Lei, MD
Katalin Scherer, MD (EMG guided neurotoxin injections (“botox”)